|
|
| Тема |
 Нов лицензиран лек за автоимунни... |
|
| Автор |
womanfree (минаващ) |
|
| Публикувано | 04.10.04 00:47 |
|
|
|
Лизензирано е ново лекарство за автоимунни заболявания, вкл. МС:
MedImmune and GenPat77 Sign License and Collaboration Agreement on Novel Therapeutic Target
Thursday September 30, 3:09 pm ET
- Companies to Generate and Evaluate Compounds for Potential Treatment of Autoimmune Diseases -
GAITHERSBURG, Md. and BERLIN, Sept. 30 /PRNewswire-FirstCall/ -- GenPat77 announced today that it has granted MedImmune, Inc. (Nasdaq: MEDI - News) an exclusive license to GenPat77's proprietary TIRC7 program, currently in preclinical development. The collaboration calls for the identification and development of biologics and small molecules targeting TIRC7, a molecule that is implicated in immune regulation, and therefore may be useful in the treatment of rheumatoid arthritis, multiple sclerosis and other immunological diseases.
The sky is the limit! Редактирано от womanfree на 04.10.04 00:50.
| |
| |
| 
|
|
